Target $13
https://www.benzinga.com/stock/DVAX/ratings
Friday, October 18, 2019
RedHill Bio in-licenses Cosmo Pharma’s Aemcolo rights in U.S.
RedHill Biopharma (NASDAQ:RDHL) is up 10% premarket after entering into an exclusive license agreement with Cosmo Pharmaceuticals N.V. (OTC:CMOPF)
for U.S. rights to Aemcolo (rifamycin) for Traveler’s Diarrhea and a
simultaneous private investment by Cosmo of $36.3M in RedHill.
As part of the Aemcolo license agreement, RedHill
will issue Cosmo 1,714,286 ADSs at $7/ADS at an agreed value of $12M, as
an upfront payment.
These ADSs are in addition to the ADSs issued to
Cosmo as part of the $36.3M investment. In addition, RedHill will pay a
royalty percentage in the high twenties on net sales of Aemcolo in U.S.
The license agreement further provides for potential milestone payments to Cosmo totaling up to $100M.
https://seekingalpha.com/news/3506806-redhill-bio-licenses-cosmo-pharmas-aemcolo-rights-u-s-shares-10-percent-premarketEuropean advisory group backs Merck Ebola vaccine
The European advisory group CHMP has adopted a positive opinion recommending approval of Merck’s (NYSE:MRK)
V920 Ebola Zaire vaccine, branded as ERVEBO, for active immunization of
people at least 18 years old to protect against Ebola Virus Disease
(EVD) caused by the Zaire Ebola virus.
A final decision from the European Commission usually takes ~60 days.
https://seekingalpha.com/news/3506814-european-advisory-group-backs-merck-ebola-vaccineEuropean advisory group backs Lilly’s nasally administered glucagon
The European advisory group CHMP has adopted a positive opinion recommending approval of Eli Lilly’s (NYSE:LLY) Baqsimi (glucagon) for severe hypoglycemia (low blood sugar).
The product is administered through the nose via a
single-use dispenser. The recipient does not have to inhale or breathe
deeply after dosing, enabling delivery even in someone unconscious.
Other glucagons are administered via injection.
A final decision from the European Commission usually takes ~60 days.
https://seekingalpha.com/news/3506826-european-advisory-group-backs-lillys-nasally-administered-glucagon
Subscribe to:
Posts (Atom)